Brainstorm Cell Therapeutics reported $5.28M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acceleron Pharma XLRN:US $ 104.83M 13.23M
Biogen BIIB:US $ 1984.9M 304.4M
Brainstorm Cell Therapeutics BCLI:US $ 5.28M 844K
Cerulean Pharma CERU:US $ 12.67M 3.51M
Cytokinetics CYTK:US $ 74.64M 17M
Gilead Sciences GILD:US $ 3579M 392M
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Idera Pharmaceuticals IDRA:US $ 5.97M 1.59M